CMS Open Payments · Program Year 2024
Genesis Innovation Group, Inc.
Genesis Innovation Group, Inc. reported $136.00 across General Payments, Research, and Ownership to 1 physicians and teaching hospitals across 1 transactions.
- $136.00
- All-tracks total
- 1
- Transactions
- 1
- Recipients
- #1903
- of 1,925 companies
Genesis Innovation Group, Inc. reported $136.00 across all CMS Open Payments tracks (General + Research + Ownership) to 1 physicians and teaching hospitals in Program Year 2024 - ranking #1903 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $136.00, averaging $136.00 per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer genesis-innovation-group-inc Genesis Innovation Group, Inc.
$136.00 · #1903/1,925 · 0.0% industry · PY2024
- TOT $136.00
- RANK #1903
- SHARE 0.0%
- TXN 1
- RCP 1
- CAT 1
- GEN $136.00
- TOP1 100.0%
- PY 2024
Volume peers
Nearest volume peer: Kinex Medical Company LLC ($133.04)
Genesis Innovation Group, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Genesis Innovation Group, Inc.
In Program Year 2024, Genesis Innovation Group, Inc. reported $136.00 in payments to 1 physicians and teaching hospitals across 1 individual transactions, an average of $136.00 per transaction and $136.00 per recipient. That total places Genesis Innovation Group, Inc. at rank #1903 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.
"Food and Beverage" leads the 1-category general-payment breakdown below at $136.00 (100.0% of General Payments, 1 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
Genesis Innovation Group, Inc. made 1 types of general payments. "Food and Beverage" is the largest category at $136.00, 100.0% of General Payments.
How Genesis Innovation Group, Inc. divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $136.00 | 1 | 100.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $136.00 (100.0%) of $136.00 in this company's General Payments records across 1 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Genesis Innovation Group, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Krishna Vemulapalli
$136.00 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Genesis Innovation Group, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Genesis Innovation Group, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Genesis Innovation Group, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Vy Spine LLC
Gunze International USA, Inc.
Elekta Pty Ltd
FUJIFILM Holdings America Corporation
Lifescan, Inc.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.